首頁 > 市場調查報告書 > 醫療設備

手術用器具

封堵器市場規模、佔有率及成長分析（按產品、應用、最終用戶和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1900736

封堵器市場規模、佔有率及成長分析（按產品、應用、最終用戶和地區分類）－2026-2033年產業預測

Occlusion Devices Market Size, Share, and Growth Analysis, By Product (Occlusion Removal Devices, Embolization Devices), By Application (Neurology, Cardiology), By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月23日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球閉塞裝置市場規模預計在 2024 年達到 30.9 億美元，從 2025 年的 32.5 億美元成長到 2033 年的 48.3 億美元，在預測期（2026-2033 年）內複合年成長率為 5.1%。

全球血管閉塞裝置市場持續穩定成長，主要驅動力是心血管、神經血管和周邊血管疾病日益成長的增加。包括栓塞裝置和支撐裝置在內的各種血管閉塞裝置對於有效治療至關重要。人口老化和微創手術技術的進步也進一步加速了市場成長。血管內治療（尤其是在門診手術中心）的日益普及以及對門診服務需求的成長，都推動了對這些裝置的需求。北美地區由於心血管疾病的高發病率和主要行業參與者的存在，佔據了市場主導地位。然而，由於醫療基礎設施的改善和患者意識的提高，歐洲和亞太地區也經歷了快速成長。總體而言，預計該市場將保持持續成長。

全球封堵器市場成長要素

心血管、神經血管和周邊血管疾病的日益普遍是推動全球血管閉塞裝置市場成長的主要因素。這些疾病需要有效的治療方案，包括血管閉塞裝置，以恢復血流並預防併發症。隨著人口老化和不良生活方式等因素導致這些疾病的全球負擔加重，對血管閉塞裝置的需求也持續增加。這一趨勢凸顯了開發創新醫療技術以應對健康挑戰並改善不同患者群體治療效果的緊迫性。

限制全球封堵器市場發展的因素

全球血管閉塞器械市場面臨嚴峻的挑戰，這主要源於嚴格的監管核准流程，該流程優先考慮病患安全和產品療效。從監管機構和其他管道獲得必要的核准可能耗時耗力。這些法規的嚴格性，加上對特定品質標準的要求，為市場參與企業，尤其是中小企業，設置了重重障礙。這些障礙會阻礙市場准入和業務擴張，最終影響產業的競爭格局和創新。

全球封堵器市場趨勢

在全球封堵器市場，生物可吸收裝置的普及應用已成為一個顯著趨勢，其驅動力在於市場對能夠提升患者舒適度和安全性的創新解決方案的需求日益成長。這些裝置旨在被人體自然溶解，無需再次手術取出，並顯著降低長期併發症的風險。隨著醫療保健不斷向以患者為中心和個人化治療方案發展，製造商正大力投資研發，以改善生物可吸收材料，確保其有效性和安全性。對這些先進的微創治療方法日益成長的關注正在重塑市場競爭格局。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Boston Scientific Corporation（United States）
Medtronic PLC（Ireland）
Terumo Corporation（Japan）
Stryker Corporation（United States）
Penumbra, Inc.（United States）
Abbott Laboratories（United States）
Edwards Lifesciences Corporation（United States）
Johnson & Johnson（United States）
Merit Medical Systems, Inc.（United States）
Lepu Medical Technology Co., Ltd.（China）
Asahi Intecc Co., Ltd.（Japan）
AngioDynamics, Inc.（United States）
Cardinal Health, Inc.（United States）
Avinger, Inc.（United States）
B. Braun Melsungen AG（Germany）
CR Bard, Inc.（United States）
Cook Medical Incorporated（United States）
Acrostak International Distribution Sarl（Switzerland）

結論與建議

簡介目錄

Product Code: SQMIG35A2550

Global Occlusion Devices Market size was valued at USD 3.09 Billion in 2024 and is poised to grow from USD 3.25 Billion in 2025 to USD 4.83 Billion by 2033, growing at a CAGR of 5.1% during the forecast period (2026-2033).

The global occlusion devices market is undergoing robust expansion, primarily driven by the rise in cardiovascular diseases, neurovascular conditions, and peripheral vascular issues. Various types of occlusion devices, such as embolization and support devices, are essential for effective treatment. Market growth is further propelled by an aging population and advancements in minimally invasive surgical techniques. The increasing adoption of endovascular procedures and rising preference for outpatient services, particularly in ambulatory surgical centers, are enhancing demand for these devices. North America dominates the market share due to a high prevalence of cardiovascular diseases and the presence of major industry players, while Europe and Asia-Pacific are also experiencing rapid growth owing to improved healthcare infrastructure and growing patient awareness. Overall, the market is poised for sustained growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Occlusion Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Occlusion Devices Market Segments Analysis

Global Occlusion Devices Market is segmented by Product, Application, End User and region. Based on Product, the market is segmented into Occlusion Removal Devices, Embolization Devices and Support Devices. Based on Application, the market is segmented into Neurology, Cardiology, Peripheral Vascular Diseases, Urology,oncologyand Gynecology. Based on End User, the market is segmented into Hospitals, Diagnostic Centers,, Surgical Centers, Ambulatory Care Centers and Research Laboratories & Academic Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Occlusion Devices Market

The increasing prevalence of cardiovascular diseases, neurovascular disorders, and peripheral vascular diseases serves as a major catalyst for the growth of the global occlusion devices market. These medical conditions necessitate effective treatment solutions, including occlusion devices, aimed at restoring blood flow and averting further complications. As the global burden of these disorders rises, driven by factors such as an aging population and deteriorating lifestyle choices, the demand for occlusion devices continues to expand. This trend underscores the urgent need for innovative medical technologies to address these health challenges and improve patient outcomes across diverse populations.

Restraints in the Global Occlusion Devices Market

The Global Occlusion Devices market faces significant challenges due to rigorous regulatory approval processes that prioritize patient safety and product effectiveness. Securing necessary approvals, such as those required from regulatory bodies, can be both a lengthy and expensive endeavor. The demanding nature of these regulations, along with the requirement to adhere to specific quality standards, creates obstacles for market participants, especially for small and medium-sized enterprises. These hurdles can hinder their ability to enter the market or expand their operations, ultimately affecting the competitive landscape and innovation within the industry.

Market Trends of the Global Occlusion Devices Market

The Global Occlusion Devices market is witnessing a notable trend towards the adoption of bioresorbable devices, driven by an increasing demand for innovative solutions that enhance patient comfort and safety. These devices, designed to naturally dissolve within the body, eliminate the need for additional surgical procedures for removal, significantly reducing the risk of long-term complications. As healthcare continues to evolve towards more patient-centric and personalized treatment options, manufacturers are heavily investing in research and development to improve bioresorbable materials and ensure their efficacy and safety. This growing emphasis on advanced, less invasive interventions is reshaping the competitive landscape of the market.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technological Advancement

Global Occlusion Devices Market Size by Product & CAGR (2026-2033)

Market Overview
Occlusion Removal Devices
- Balloon Occlusion Devices
- Stent Retrievers
- Coil Retrievers
- Suction & Aspiration Devices
Embolization Devices
- Embolic Coils
- Liquid Embolic Agents
- Tubal Occlusion Devices
Support Devices
- Microcatheters
- Guidewires

Global Occlusion Devices Market Size by Application & CAGR (2026-2033)

Market Overview
Neurology
Cardiology
Peripheral Vascular Diseases
Urology
Oncology
Gynecology

Global Occlusion Devices Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals
Diagnostic Centers,
Surgical Centers
Ambulatory Care Centers
Research Laboratories & Academic Institutes

Global Occlusion Devices Market Size & CAGR (2026-2033)

North America (Product, Application, End User)
- US
- Canada
Europe (Product, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Boston Scientific Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic PLC (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Penumbra, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Edwards Lifesciences Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merit Medical Systems, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lepu Medical Technology Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Asahi Intecc Co., Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AngioDynamics, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Avinger, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun Melsungen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
C.R. Bard, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical Incorporated (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Acrostak International Distribution Sarl (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments